Developer docs
API playgroundTry for free, no card

Search company profiles

Calea

Full company profile

uuid00087vo

Namestring
Calea
Legal namestring
Calea (Canada)
Websiteurl
calea.ca
Company typeenum
Private
Founded yearint
1984
Descriptiontext

Calea (Canada) was a Canadian specialty pharmacy operator founded in 1984, running four physical pharmacy locations in Mississauga and Hamilton, Ontario; Calgary, Alberta; and Burnaby, British Columbia. Its core services spanned four integrated lines: Specialty Pharmacy (customized medication programs for complex conditions), Infusion Compounding (home or clinic-based IV therapy), Retail Pharmacy (standard prescription fulfillment), and Total Parenteral Nutrition (TPN) for patients unable to receive enteral nutrition. The underlying technology stack described is pharmaceutical compounding and specialty pharmacy operations — there is no proprietary software, AI/ML, or platform IP disclosed, and no patents or trademarks are on file in the source data.

The business model is transaction-based pharmacy services revenue: prescriptions and infusions are dispensed to individual patients and billed through a mix of healthcare insurance, Canadian public drug plans (provincial formularies), and direct patient payments for uncovered medications. The go-to-market motion is enterprise field sales in the sense of healthcare provider referral networks and direct patient engagement through pharmacy counters, not a software-style enterprise sales motion. No disclosed enterprise customers, ARR, or revenue figures are available; customer segments are vertical use-cases (specialty, infusion, retail, TPN) rather than named accounts.

In August 2025, Calea was acquired by Capital Health Partners Inc — the parent of Ontario Medical Supply and Royal Drugs — and effective November 14, 2025 the four pharmacy locations were rebranded under the Royal Drugs name, unifying pharmacy services under a single brand alongside sister company Ontario Medical Supply. CEO Yves Portelance leads the combined entity. The company employs 251–500 people. A notice of a data security event is currently displayed on the company website, indicating an active compliance matter.

Short descriptiontext

Calea (now Royal Drugs) is a Canadian specialty pharmacy operator with four locations in Ontario, Alberta, and British Columbia offering specialty medications, infusion compounding, retail prescriptions, and total parenteral nutrition to patients with complex medical needs, now owned by Capital Health Partners.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy services, infusion compounding, total parenteral nutrition, retail prescription dispensing, pharmaceutical compounding
Industry1 code
PRIMARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Pharmacies and Drug Retailers456110
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Specialty Pharmacy Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmacy Services Revenue
TypeSubscription Recurring
Description

Revenue generated from dispensing specialty medications, infusion therapy compounding, retail prescriptions, and total parenteral nutrition services. Services are billed through healthcare insurance, public drug plans, and direct patient payments for uncovered medications.

royaldrugs.ca
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Specialty Pharmacy Services
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Pricing varies by medication and insurance coverage; public drug plans and private insurance accepted.

royaldrugs.ca
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Calea (now operating under the Royal Drugs brand as of November 14, 2025) is a Canadian specialty pharmacy that dispenses customized specialty medications, compounds and administers infusion therapies in home or clinic settings, fills retail prescriptions, and prepares total parenteral nutrition (TPN) formulations. Services are delivered through four pharmacy locations in Ontario, Alberta, and British Columbia and billed through public drug plans, private insurance, and direct patient payment.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Royal Drugs (formerly Calea) operates as a unified pharmacy platform offering four integrated core services: Specialty Pharmacy for customized medication programs, Infusion Compounding for home or clinic-based therapy, Retail Pharmacy for standard prescription services, and Total Parenteral Nutrition (TPN) for patients with advanced nutritional needs. The four pharmacy locations were consolidated under the Royal Drugs brand following the August 2025 acquisition by Capital Health Partners.

Product and service4 records
1Specialty Pharmacy
CategorySpecialty Pharmacy Service
Description

Customized specialty medication programs designed to streamline healthcare practice workflows and support patients with complex medication needs, including chronic and rare disease therapies.

2Infusion Compounding
CategoryInfusion Therapy Service
Description

Sterile compounding and administration of intravenous or injectable infusion therapies delivered safely and conveniently at the patient's home or in a clinic setting.

3Retail Pharmacy
CategoryRetail Pharmacy Service
Description

Fast and friendly prescription dispensing and pharmacy services at local pharmacy counters for standard medication needs of the general public.

4Total Parenteral Nutrition (TPN)
CategoryParenteral Nutrition Service
Description

Custom-compounded intravenous nutrition formulations for patients with advanced nutritional needs who cannot receive nutrition orally or enterally.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Ontario Medical Supply is a sister company under Capital Health Partners Inc, operating alongside Royal Drugs. Both companies are subsidiaries of Capital Health Partners Inc.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-based specialty pharmacy owned by Evernorth/Cigna. Comparable specialty pharmacy and infusion services model at much larger US scale; serves as an upstream strategic comparable for Royal Drugs' growth pathway.

2Pharmasave
TypeDirect peer
Description

Canadian independent pharmacy network with prescription services and select specialty capabilities across the country. Comparable community-pharmacy operating model.

TypeDirect peer
Description

Canada's largest specialty pharmacy and patient support provider, owned by Cencora (formerly AmerisourceBergen). Closely matches Royal Drugs' specialty pharmacy + infusion + patient services offering, but at materially greater scale.

TypeDirect peer
Description

Canadian home and community healthcare services provider offering specialty pharmacy, infusion therapy, and compounding services. Closely comparable to Royal Drugs on home infusion and specialty pharmacy model in Canada.

5Shoppers Drug Mart (Loblaw Companies)
TypeDirect peer
Description

Canada's largest retail pharmacy chain, part of Loblaw, with growing specialty pharmacy capabilities. Comparable pharmacy footprint and dispensing model across Canada.

TypeBroad incumbent
Description

Specialty pharmacy arm of CVS Health offering specialty medications, infusion, and care management nationally in the US. Comparable multi-modality specialty pharmacy business model, though at materially larger scale.

7London Drugs
TypeDirect peer
Description

Western Canadian retail pharmacy chain with prescription dispensing across BC, Alberta, Saskatchewan, and Manitoba. Geographic overlap in Calgary and Burnaby markets.

TypeBroad incumbent
Description

Major pharmaceutical distributor in Canada and parent of Rexall; broader portfolio spans wholesale distribution, retail pharmacy, and specialty services — overlapping with Royal Drugs' dispensing and distribution-adjacent activities.

TypeDirect peer
Description

Canadian retail pharmacy chain owned by McKesson, with pharmacy dispensing and specialty medication services across multiple provinces.

TypeDirect peer
Description

Canadian specialty pharmacy network providing specialty medications, infusion services, and patient support programs. Direct comparable in specialty pharmacy + patient support across Canada.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calea

Specialty Pharmacy Servicescalea.ca

Calea (now Royal Drugs) is a Canadian specialty pharmacy operator with four locations in Ontario, Alberta, and British Columbia offering specialty medications, infusion compounding, retail prescriptions, and total parenteral nutrition to patients with complex medical needs, now owned by Capital Health Partners.

What Calea does

Calea (Canada) was a Canadian specialty pharmacy operator founded in 1984, running four physical pharmacy locations in Mississauga and Hamilton, Ontario; Calgary, Alberta; and Burnaby, British Columbia. Its core services spanned four integrated lines: Specialty Pharmacy (customized medication programs for complex conditions), Infusion Compounding (home or clinic-based IV therapy), Retail Pharmacy (standard prescription fulfillment), and Total Parenteral Nutrition (TPN) for patients unable to receive enteral nutrition. The underlying technology stack described is pharmaceutical compounding and specialty pharmacy operations — there is no proprietary software, AI/ML, or platform IP disclosed, and no patents or trademarks are on file in the source data.

The business model is transaction-based pharmacy services revenue: prescriptions and infusions are dispensed to individual patients and billed through a mix of healthcare insurance, Canadian public drug plans (provincial formularies), and direct patient payments for uncovered medications. The go-to-market motion is enterprise field sales in the sense of healthcare provider referral networks and direct patient engagement through pharmacy counters, not a software-style enterprise sales motion. No disclosed enterprise customers, ARR, or revenue figures are available; customer segments are vertical use-cases (specialty, infusion, retail, TPN) rather than named accounts.

In August 2025, Calea was acquired by Capital Health Partners Inc — the parent of Ontario Medical Supply and Royal Drugs — and effective November 14, 2025 the four pharmacy locations were rebranded under the Royal Drugs name, unifying pharmacy services under a single brand alongside sister company Ontario Medical Supply. CEO Yves Portelance leads the combined entity. The company employs 251–500 people. A notice of a data security event is currently displayed on the company website, indicating an active compliance matter.

Calea firmographics

Firmographics
Name
Calea
Legal name
Calea (Canada)
Website
https://calea.ca
Company type
Private
Founded year
1984
Operating status
Acquired
Headcount range
101–250 employees
Short description
Calea (now Royal Drugs) is a Canadian specialty pharmacy operator with four locations in Ontario, Alberta, and British Columbia offering specialty medications, infusion compounding, retail prescriptions, and total parenteral nutrition to patients with complex medical needs, now owned by Capital Health Partners.
Ownership category
akta.pro rank

Calea industry classification

Industry
Product category
Specialty Pharmacy Services
NAICS
Pharmacies and Drug Retailers (456110)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Specialty pharmacy services
  • Infusion compounding
  • Total parenteral nutrition
  • Retail prescription dispensing
  • Pharmaceutical compounding

Where Calea is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Offices4 records

Markets served

Calea business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmacy Services Revenue: Revenue generated from dispensing specialty medications, infusion therapy compounding, retail prescriptions, and total parenteral nutrition services. Services are billed through healthcare insurance, public drug plans, and direct patient payments for uncovered medications.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goSpecialty Pharmacy Services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Calea product offering

Product offering

Core offering

Calea (now operating under the Royal Drugs brand as of November 14, 2025) is a Canadian specialty pharmacy that dispenses customized specialty medications, compounds and administers infusion therapies in home or clinic settings, fills retail prescriptions, and prepares total parenteral nutrition (TPN) formulations. Services are delivered through four pharmacy locations in Ontario, Alberta, and British Columbia and billed through public drug plans, private insurance, and direct patient payment.

Product overview

Royal Drugs (formerly Calea) operates as a unified pharmacy platform offering four integrated core services: Specialty Pharmacy for customized medication programs, Infusion Compounding for home or clinic-based therapy, Retail Pharmacy for standard prescription services, and Total Parenteral Nutrition (TPN) for patients with advanced nutritional needs. The four pharmacy locations were consolidated under the Royal Drugs brand following the August 2025 acquisition by Capital Health Partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialty Pharmacy Customized specialty medication programs designed to streamline healthcare practice workflows and support patients with complex medication needs, including chronic and rare disease therapies.
  • Infusion Compounding Sterile compounding and administration of intravenous or injectable infusion therapies delivered safely and conveniently at the patient's home or in a clinic setting.
  • Retail Pharmacy Fast and friendly prescription dispensing and pharmacy services at local pharmacy counters for standard medication needs of the general public.
  • Total Parenteral Nutrition (TPN) Custom-compounded intravenous nutrition formulations for patients with advanced nutritional needs who cannot receive nutrition orally or enterally.

Companies that use Calea

Customer profile

Segments4 records

Ideal customer profiles4 records

Calea technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Calea partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Ontario Medical SupplyminorOthersOntario Medical Supply is a sister company under Capital Health Partners Inc, operating alongside Royal Drugs. Both companies are subsidiaries of Capital Health Partners Inc.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Calea competitors and assessment

Company assessment

Broad incumbents

  • Accredo (Express Scripts / Evernorth): US-based specialty pharmacy owned by Evernorth/Cigna. Comparable specialty pharmacy and infusion services model at much larger US scale; serves as an upstream strategic comparable for Royal Drugs' growth pathway.
  • CVS Specialty (CVS Health): Specialty pharmacy arm of CVS Health offering specialty medications, infusion, and care management nationally in the US. Comparable multi-modality specialty pharmacy business model, though at materially larger scale.
  • McKesson Canada: Major pharmaceutical distributor in Canada and parent of Rexall; broader portfolio spans wholesale distribution, retail pharmacy, and specialty services — overlapping with Royal Drugs' dispensing and distribution-adjacent activities.

Direct peers

  • Pharmasave: Canadian independent pharmacy network with prescription services and select specialty capabilities across the country. Comparable community-pharmacy operating model.
  • Innomar Strategies (Cencora): Canada's largest specialty pharmacy and patient support provider, owned by Cencora (formerly AmerisourceBergen). Closely matches Royal Drugs' specialty pharmacy + infusion + patient services offering, but at materially greater scale.
  • Bayshore HealthCare: Canadian home and community healthcare services provider offering specialty pharmacy, infusion therapy, and compounding services. Closely comparable to Royal Drugs on home infusion and specialty pharmacy model in Canada.
  • Shoppers Drug Mart (Loblaw Companies): Canada's largest retail pharmacy chain, part of Loblaw, with growing specialty pharmacy capabilities. Comparable pharmacy footprint and dispensing model across Canada.
  • London Drugs: Western Canadian retail pharmacy chain with prescription dispensing across BC, Alberta, Saskatchewan, and Manitoba. Geographic overlap in Calgary and Burnaby markets.
  • Rexall Pharmacy: Canadian retail pharmacy chain owned by McKesson, with pharmacy dispensing and specialty medication services across multiple provinces.
  • BioScript Solutions: Canadian specialty pharmacy network providing specialty medications, infusion services, and patient support programs. Direct comparable in specialty pharmacy + patient support across Canada.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Calea social profiles

Digital presence

Calea financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calea leadership team

Management profile

Number of profiles

Profiles1 record

Calea funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calea M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calea

What does Calea do?

Calea (now operating under the Royal Drugs brand as of November 14, 2025) is a Canadian specialty pharmacy that dispenses customized specialty medications, compounds and administers infusion therapies in home or clinic settings, fills retail prescriptions, and prepares total parenteral nutrition (TPN) formulations. Services are delivered through four pharmacy locations in Ontario, Alberta, and British Columbia and billed through public drug plans, private insurance, and direct patient payment.

Is Calea a public or private company?

Calea is a private company. It is classified as corporate owned and is currently acquired.

When was Calea founded?

Calea was founded in 1984. It employs 101 to 250 people.

Where is Calea based?

Calea is headquartered in Mississauga, Canada, in the North America region.

How does Calea make money?

One revenue line is on record: pharmacy Services Revenue.

Who are Calea's main competitors?

Broad incumbents on record are Accredo (Express Scripts / Evernorth), CVS Specialty (CVS Health) and McKesson Canada. Direct peers are Pharmasave, Innomar Strategies (Cencora), Bayshore HealthCare, Shoppers Drug Mart (Loblaw Companies), London Drugs, Rexall Pharmacy and BioScript Solutions.

Does Calea have an API?

No public API is recorded for Calea.

What industry is Calea in?

Calea's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals